MMRGlobal, Inc. (OTCQB: MMRF) today announced it has filed a Form 8-K regarding the signing of another royalty-based licensing agreement. On December 17, 2012, MyMedicalRecords, Inc. ("MMR") signed a Non-Exclusive Patent License Agreement with Healthcare Holdings Group, Inc. ("HCH"), the parent of Access My Records, Inc., to license the U.S. rights for the health IT patents owned by MyMedicalRecords, Inc. These include but are not limited to U.S. Patent Numbers 8,321,240; 8,301,466; 8,117,045; 8,117,646; and 8,121,855, as well as any other health IT patents to be issued pursuant to pending applications filed by MyMedicalRecords in the United States and all divisions, continuations, reissues, and extensions (the "MMR Patents"). The initial term of the Agreement is five years and automatically renews to the expiration date of the last licensed patent to expire, which currently in the U.S. is twenty years from the date of filing. MMRGlobal is a leading provider of Personal Health Records (PHRs) including its MyMedicalRecords.com PHR and MMRPro document management and imaging systems for healthcare professionals.

According to Robert H. Lorsch, MMRGlobal Chairman and CEO, "We are pleased that we have been able to announce royalty-based license agreements with EHR vendors, surgery centers, and now a PHR vendor, in addition to entering into relationships with retailers and others as a direct result of the Company's patented IP in our products and services. As a result of recently issued patents and Notices of Allowance, we are continuing to discuss other licensing relationships with hospitals, physician groups, retail pharmacies, patient monitoring and telemedicine service providers and laboratories, as well as other software and equipment vendors in the healthcare and wellness markets."

Healthcare Holdings Group, Inc. is a comprehensive Electronic Health Record systems provider. HCH's solutions are designed for General Practice and Chiropractic disciplines. The company's software systems include ChartZoneMD, an EHR cloud-based software solution, and SmartFormsMD, a Voice Recognition Medical Dictionary module. HCH, through its wholly-owned operating subsidiary, Access My Records, Inc., provides the AccessMyRecords.com Personal Health Record and a free-standing Patient Portal designed to seamlessly connect to any EHR system. 

"We have been following MyMedicalRecords' efforts to provide untethered standardized solutions to how patients share medical information with their doctors," said Leonard Tambasco, Chairman and CEO of Healthcare Holdings Group, Inc. "In spite of the fact that our two companies regularly compete in the marketplace, we recognize the importance of MMR's Patent Portfolio as we approach requirements under the HITECH Act mandating the use of Personal Health Records and Patient Portals by 2014. Therefore, for the benefit of our clients and shareholders, we have made the decision to license the technology at this time. Although we approach the market differently, we both have a mission to provide seamless connectivity between patients and physicians. The Agreement with MMR is consistent with HCH's position to enhance and support industry-wide standardization efforts. HCH will launch its MU-1 compliant EHR at HIMSS13."

About MMRGlobal
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.

About Healthcare Holdings Group, Inc.

Healthcare Holdings Group, Inc. (HCH) provides the Electronic Health Records (EHR) software suite, ChartZoneMD, designed to give physicians' offices an easy and cost-effective cloud-based practice management solution. ChartZoneMD's suite of applications, tools, and technology allow clinicians to seamlessly transit from paper charts to the recently mandated Meaningful Use EHR format and reporting styles. In addition, HCH has developed SmartFormsMD, a free-standing, time-saving, error-reducing, customizable, medical voice-command module complete with medical dictionary integration and specialty accommodation. The ChartZoneMD Software Suite enables real-time sharing of medical records with patients via the Access My Records integrated patient-portal module. For more information, visit www.healthcareholdingsgroup.com.

Forward-Looking Statements

All statements in this press release that are not strictly historical in nature including, without limitation, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: actual or unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation or licensing transactions; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and internationally; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.